Plug-and-Play Continuous Gas Flow Assembly of Cysteine-Inserted AuCu Nanobimetals for Folate-Receptor-Targeted Chemo-Phototherapy
Source abstract
Abstract
Conjugatable nanobimetals exhibiting broadband light absorption for use as phototherapeutic platforms were assembled via a plug-and-play continuous gas flow route. Electrically produced AuCu nanobunches (NBs) under nitrogen gas flow were directly injected into cysteine (cys) solution through gas pressurization to mechanically spray the solution (AuCu into cys droplets). The sprayed droplets were then exposed to 185 nm UV light (higher photon energy [6.2 eV] than the work functions of Au [5.1 eV] and Cu [4.7 eV]) to initiate photoionization of AuCu NBs for subsequent electrostatic reaction with the SH– group of cys to form cys-inserted AuCu (AuCu-cys) platforms in a single-pass gas stream. These platforms exhibited broadband light absorption spectra because of hybridized interparticle plasmonic coupling and could be conjugated to folic acid (FA) when dispersed in FA solution to form highly dispersible, biocompatible, and cancer-targetable AuCu-cys-FA. This material was suitable for use in targeted phototherapy of folate-receptor (FR)-rich cancers via FR-mediated endocytosis, and loading doxorubicin (DOX) into AuCu-cys-FA (i.e., AuCu-cys-DOXFA) facilitated chemo-phototherapy because of photoresponsive anticancer drug release upon induction of hyperthermia.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Innovative Microfluidic and Catalytic Techniques Innovation · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Mechanical Engineering, Yonsei University, Seoul 03722, Republic of Korea
College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea
References (58)
Show source-provided references
1. 10.1002/smll.20160102310.1002/smll.201601023 ↗
2. 10.1021/nn500222q10.1021/nn500222q ↗
3. 10.1021/acs.jpcc.5b0272810.1021/acs.jpcc.5b02728 ↗
4. 10.1016/j.colsurfb.2017.09.01010.1016/j.colsurfb.2017.09.010 ↗
5. 10.1007/s11468-013-9607-x10.1007/s11468-013-9607-x ↗
6. 10.1021/acs.chemrev.6b0021110.1021/acs.chemrev.6b00211 ↗
7. 10.1002/adfm.20120166310.1002/adfm.201201663 ↗
8. 10.1002/smll.20140136010.1002/smll.201401360 ↗
9. 10.1073/pnas.150162811210.1073/pnas.1501628112 ↗
10. 10.1007/s11051-013-1537-110.1007/s11051-013-1537-1 ↗
11. 10.1126/science.aao346610.1126/science.aao3466 ↗
12. 10.1016/j.apt.2013.12.00510.1016/j.apt.2013.12.005 ↗
13. 10.1007/s11051-009-9603-410.1007/s11051-009-9603-4 ↗
14. 10.1038/ncomms594810.1038/ncomms5948 ↗
15. 10.1039/c5cp00298b10.1039/c5cp00298b ↗
16. 10.1038/ncomms532710.1038/ncomms5327 ↗
17. 10.1002/adma.20130202510.1002/adma.201302025 ↗
18. 10.1016/j.saa.2015.03.07810.1016/j.saa.2015.03.078 ↗
19. 10.1002/smll.20140041810.1002/smll.201400418 ↗
20. Jhaveri M. S. · Mol. Cancer Ther. · 2004 · 12 · 150510.1158/1535-7163.1505.3.12 ↗
21. 10.1016/j.colsurfb.2017.04.01010.1016/j.colsurfb.2017.04.010 ↗
22. 10.1148/radiol.1009005010.1148/radiol.10090050 ↗
23. 10.1016/j.colsurfb.2016.06.00410.1016/j.colsurfb.2016.06.004 ↗
24. 10.1038/srep3132910.1038/srep31329 ↗
25. 10.1021/acsami.6b0690310.1021/acsami.6b06903 ↗
26. 10.1039/c2sc00016d10.1039/c2sc00016d ↗
27. 10.1021/ja031547r10.1021/ja031547r ↗
28. 10.1002/advs.20170056310.1002/advs.201700563 ↗
29. 10.1038/srep1613710.1038/srep16137 ↗
30. 10.1039/b907301a10.1039/b907301a ↗
31. 10.1038/ncomms534810.1038/ncomms5348 ↗
32. 10.1016/j.jaerosci.2008.05.00610.1016/j.jaerosci.2008.05.006 ↗
33. 10.1039/c5ra01271f10.1039/c5ra01271f ↗
34. 10.1039/c3cc44256j10.1039/c3cc44256j ↗
35. 10.1021/cm048445010.1021/cm0484450 ↗
36. 10.1002/anie.20130898610.1002/anie.201308986 ↗
37. 10.1002/adma.20120221110.1002/adma.201202211 ↗
38. 10.1021/nn406382510.1021/nn4063825 ↗
39. 10.1021/cm302097c10.1021/cm302097c ↗
40. 10.1021/cm903038w10.1021/cm903038w ↗
41. 10.1039/c6ra00177g10.1039/c6ra00177g ↗
42. 10.1039/c7mh01071k10.1039/c7mh01071k ↗
43. 10.1016/j.ijpharm.2018.06.05610.1016/j.ijpharm.2018.06.056 ↗
44. 10.1016/j.jconrel.2014.06.03810.1016/j.jconrel.2014.06.038 ↗
45. 10.1016/j.bmc.2005.02.02510.1016/j.bmc.2005.02.025 ↗
46. 10.1016/j.bbamem.2010.12.01410.1016/j.bbamem.2010.12.014 ↗
47. 10.1039/c3pp25384h10.1039/c3pp25384h ↗
48. 10.1038/srep1673310.1038/srep16733 ↗
49. Sun Y. · Am J Cancer Res · 2016 · 6 · 114
50. 10.1111/j.2042-7158.2012.01567.x10.1111/j.2042-7158.2012.01567.x ↗
51. 10.1093/carcin/bgr27010.1093/carcin/bgr270 ↗
52. 10.1097/cad.0b013e3282ef457110.1097/cad.0b013e3282ef4571 ↗
53. 10.1016/j.biomaterials.2015.02.12210.1016/j.biomaterials.2015.02.122 ↗
54. 10.1021/mp300560n10.1021/mp300560n ↗
55. 10.1002/adfm.20150491210.1002/adfm.201504912 ↗
56. 10.1002/med.2128010.1002/med.21280 ↗
57. 10.1016/j.actbio.2012.04.02910.1016/j.actbio.2012.04.029 ↗
58. 10.3402/nano.v3i0.1849610.3402/nano.v3i0.18496 ↗